Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$87,594
-$214,776 QoQ
Shares Held
72,996
-76.3% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. FATE ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $87,594 | 72,996 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $302,370 | 308,542 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $265,213 | 210,487 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $507,439 | 453,072 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $290,155 | 367,285 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $687,605 | 416,731 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,484,969 | 424,277 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $403,071 | 122,888 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,379,942 | 324,243 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $1,344,061 | 359,375 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $251,751 | 118,751 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $2,280,511 | 479,099 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $2,854,684 | 500,822 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,662,498 | 263,875 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $4,009,484 | 178,915 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $515,844 | 20,817 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $829,599 | 21,398 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,214,814 | 106,218 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $3,244,912 | 54,748 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,692,392 | 42,544 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,051,278 | 109,779 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $11,807,169 | 129,849 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,354,870 | 158,991 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,688,598 | 136,654 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,433,593 | 109,572 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||